Clinical development and commercialization of innovative aesthetics and medical dermatology products based on scientific breakthroughs
Sienna Biopharmaceuticals (“sienna”) is a company focused on the discovery, clinical development and commercialization of products in aesthetics and dermatology based on scientific breakthroughs that dramatically improve patient outcomes and physicians’ practice of medicine.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 24, 2017 | Series B | $40M | 1 |
![]() |
— | Detail |
Jul 12, 2016 | Series A | $12M | 1 |
![]() |
— | Detail |
Apr 28, 2016 | Series A | $34M | 1 |
![]() |
— | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
![]() |
Yes | Series B |